SCHEDULE: Dodge & Cox Discloses 13.9% Stake in Elanco Animal Health

Dodge & Cox has reported a beneficial ownership of 13.9% in Elanco Animal Health Incorporated as of March 31, 2026, holding 68,944,100 shares.

Summary

• Dodge & Cox, an investment management firm, has filed a Schedule 13G, indicating their beneficial ownership of Elanco Animal Health Incorporated common stock.
• As of March 31, 2026, Dodge & Cox beneficially owns 68,944,100 shares, representing 13.9% of the class of securities.
• The firm has sole voting power over 65,566,800 shares and sole dispositive power over all 68,944,100 shares.
• Dodge & Cox manages various investment vehicles, including the Dodge & Cox Stock Fund, which holds a significant portion of these shares.
• Clients of Dodge & Cox have the right to receive or direct the receipt of dividends and proceeds from the sale of these securities.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive signal, as a large, reputable investment firm increasing or maintaining a significant stake in a company typically reflects confidence in its underlying value and future performance.

Positives

• Dodge & Cox, a significant investment manager, has publicly disclosed a substantial stake in Elanco Animal Health, signaling confidence.
• The Dodge & Cox Stock Fund, a registered investment company, holds 9.1% of the class of securities, indicating a strong conviction in Elanco's value.
• The filing confirms that Dodge & Cox manages these shares in the ordinary course of business, not for the purpose of influencing control.

Future Outlook

This filing does not contain forward-looking statements or guidance from Elanco Animal Health. It solely reports on Dodge & Cox's beneficial ownership.

Industry Context

StockSavvy.ai notes that a significant Schedule 13G filing by a major asset manager like Dodge & Cox often indicates a strong conviction in the company's long-term prospects within the animal health sector, a market characterized by steady demand and innovation.

Stakeholder Impact

• Shareholders may view the increased stake by Dodge & Cox as a positive endorsement, potentially boosting investor confidence.
• The filing does not directly impact employees, customers, suppliers, or creditors, as it pertains to investment ownership.

Key Dates

Recommendation

This filing indicates a significant investment by a major asset manager, suggesting a positive outlook on Elanco Animal Health. However, as it's a disclosure of existing holdings rather than new operational or financial results, it warrants a 'hold' recommendation, encouraging investors to monitor Elanco's performance and future disclosures.

Keywords

Elanco Animal Health, Dodge & Cox, Schedule 13G, Beneficial Ownership, Investment Management, Securities Filing, Common Stock, Institutional Investor